Literature DB >> 11420718

In vivo analysis of the model tyrosine aminotransferase gene reveals multiple sequential steps in glucocorticoid receptor action.

T Grange1, L Cappabianca, M Flavin, H Sassi, H Thomassin.   

Abstract

We are studying the mechanisms of transcriptional activation by nuclear receptors and we focus our studies on the glucocorticoid regulation of the model tyrosine aminotransferase gene. Rather than using in vitro biochemical approaches, we determine the actual events occurring in the cells. Our experimental approaches include genomic footprinting, chromatin immunoprecipitation, in situ hybridization and transgenic mice. Our results show that the glucocorticoid receptor uses a dynamic multistep mechanism to recruit successively accessory DNA binding proteins that assist in the activation process. Chromatin is first remodelled, DNA is then demethylated, and the synthesis of an accessory factor is induced. Efficient transcription induction is finally achieved upon the formation of a 'stable' multiprotein complex interacting with the regulatory element. We discuss: the relative contribution of histone acetyltransferases and ATP-dependent remodelling machines to the chromatin remodelling event; the nature of the remodelled state; the contribution of regulated DNA demethylation to gene memory during development; the mechanisms of regulated DNA demethylation; the dynamics of protein recruitment at regulatory elements; the control of the frequency of transcription pulses and the control levels of the cell-type specificity of the glucocorticoid response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420718     DOI: 10.1038/sj.onc.1204327

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Inducible DNA demethylation mediated by the maize Suppressor-mutator transposon-encoded TnpA protein.

Authors:  Hongchang Cui; Nina V Fedoroff
Journal:  Plant Cell       Date:  2002-11       Impact factor: 11.277

2.  Ligand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancy.

Authors:  Raymond D Blind; Inés Pineda-Torra; Yong Xu; H Eric Xu; Michael J Garabedian
Journal:  Biochem Biophys Res Commun       Date:  2012-03-23       Impact factor: 3.575

3.  Multimodal regulatory elements within a hormone-specific super enhancer control a heterogeneous transcriptional response.

Authors:  Jackson A Hoffman; Kevin W Trotter; Christopher R Day; James M Ward; Kaoru Inoue; Joseph Rodriguez; Trevor K Archer
Journal:  Mol Cell       Date:  2022-01-24       Impact factor: 17.970

4.  Nature of the accessible chromatin at a glucocorticoid-responsive enhancer.

Authors:  Michelle Flavin; Lucia Cappabianca; Clémence Kress; Hélène Thomassin; Thierry Grange
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 5.  Chromatin remodeling by nuclear receptors.

Authors:  Pratibha B Hebbar; Trevor K Archer
Journal:  Chromosoma       Date:  2003-02-26       Impact factor: 4.316

6.  Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes.

Authors:  Raymond D Blind; Michael J Garabedian
Journal:  J Steroid Biochem Mol Biol       Date:  2008-01-19       Impact factor: 4.292

Review 7.  The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.

Authors:  Agnes E Coutinho; Karen E Chapman
Journal:  Mol Cell Endocrinol       Date:  2010-04-14       Impact factor: 4.102

8.  Dexamethasone Treatment of Newborn Rats Decreases Cardiomyocyte Endowment in the Developing Heart through Epigenetic Modifications.

Authors:  Maresha S Gay; Yong Li; Fuxia Xiong; Thant Lin; Lubo Zhang
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

Review 9.  The BRG1 transcriptional coregulator.

Authors:  Kevin W Trotter; Trevor K Archer
Journal:  Nucl Recept Signal       Date:  2008-02-01

10.  Epigenetic Risk Factors in PTSD and Depression.

Authors:  Florian Joachim Raabe; Dietmar Spengler
Journal:  Front Psychiatry       Date:  2013-08-07       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.